Skip to content

Clinical trials

Recruiting Pulmonary Disease, Chronic Obstructive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Recruiting Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20224
20232
20245
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Sanofi3
GlaxoSmithKline2
McMaster University2
University Health Network, Toronto2
University of British Columbia2
Centre hospitalier de l'Université de Montréal (CHUM)1
Dr. J. Alberto Neder1
Dr. Juan Pablo de Torres Tajes1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive25
Asthma2
Cardiovascular Diseases2
Dyspnea2
Emphysema2
Lung Diseases, Interstitial2
Bronchitis, Chronic1
Chronic Cough1
Hyperemia1
Hypertension1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.